MAIN | LICENSE AND REGISTRY | CONTENTS INDEX | CONTACT |
MONOCLONAL ANTIBODY INDEX. Cancer -- 2012 update.
MOAB DATA TABLE (Ordered by MOAB NAME). |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
OUR ID | MOAB NAME | RELATED MOAB | SPECIES | IG TYPE | MOAB/CELL LINE CHARACTERISTICS | TARGET CELL/TISSUE | TARGET CANCER(*) | AG/EPITOPE NAME | AG Mw/kDa (ip) | AG/EPITOPE CHARACTERISTICS | STUDY PHASE(**) | PATENT ASSIGNEE/PRODUCER/DEVELOPER/DISTRIBUTOR (other names of the moab, antigen or derivatives) |
1351 | Lym-1 | IL-2 fusion proteins, chimeric (IgG1) and scFv variants, radiolabeled derivatives | m | G2a | Ka= 4.02x10(8) M(-1) / bsc= 1.1x10(6) | B lymphocytes | lymphoma (NHL), leukemia | - | 31-35 | light chain of polymorphic HLA-DR10 (class II) protein | II-III | Southern California Univ., US / Northwestern Univ., US / Techniclone, US (Oncolym) / Schering, Germany / Peregrine Pharm., US / Berlex Labs., US |